Browsing by subject "Ribonucleosides"
Now showing items 1-1 of 1
Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization. (2009-01)Tamoxifen is the most commonly used drug to treat breast cancer and acts by blocking ERalpha (oestrogen receptor alpha) signalling. Although highly effective, its usefulness is limited by the development of resistance. ...